Hls Therapeutics Stock Price on April 22, 2024
| HLTRF Stock | USD 2.40 0.04 1.64% |
If you're considering investing in HLS Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of HLS Therapeutics stands at 2.40, as last reported on the 15th of December 2024, with the highest price reaching 2.40 and the lowest price hitting 2.40 during the day. At this point, HLS Therapeutics is very risky. HLS Therapeutics holds Efficiency (Sharpe) Ratio of 0.0294, which attests that the entity had a 0.0294% return per unit of volatility over the last 3 months. We have found twenty-eight technical indicators for HLS Therapeutics, which you can use to evaluate the volatility of the firm. Please check out HLS Therapeutics' market risk adjusted performance of 0.161, and Risk Adjusted Performance of 0.0294 to validate if the risk estimate we provide is consistent with the expected return of 0.11%.
HLS Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
HLS |
Sharpe Ratio = 0.0294
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | HLTRF | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.79 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average HLS Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HLS Therapeutics by adding it to a well-diversified portfolio.
HLS Therapeutics Valuation on April 22, 2024
It is possible to determine the worth of HLS Therapeutics on a given historical date. On April 22, 2024 HLS was worth 3.85 at the beginning of the trading date compared to the closed value of 3.85. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of HLS Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find HLS Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of HLS Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against HLS Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.85 | 3.85 | 3.85 | 3.85 | 1.00 | |
04/22/2024 | 3.85 | 3.85 | 3.85 | 3.85 | 1.00 |
| 3.56 | 3.56 | 3.56 | 3.56 | 521.00 |
| Backtest HLS Therapeutics | | | HLS Therapeutics History | | | HLS Therapeutics Valuation | Previous | Next |
HLS Therapeutics Trading Date Momentum on April 22, 2024
| On April 23 2024 HLS Therapeutics was traded for 3.56 at the closing time. The highest daily price throughout the period was 3.56 and the lowest price was 3.56 . The daily volume was 521. The net trading volume on 04/23/2024 added to the next day price reduction. The trading delta at closing time to closing price of the next trading day was 7.53% . The trading delta at closing time to current closing price is 7.53% . |
HLS Therapeutics Fundamentals Correlations and Trends
By evaluating HLS Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among HLS Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. HLS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About HLS Therapeutics Pink Sheet history
HLS Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HLS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HLS Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HLS Therapeutics stock prices may prove useful in developing a viable investing in HLS Therapeutics
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada. Hls Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 92 people.
HLS Therapeutics Pink Sheet Technical Analysis
HLS Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
HLS Therapeutics Period Price Range
Low | December 15, 2024
| High |
0.00 | 0.00 |
HLS Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
HLS Therapeutics December 15, 2024 Market Strength
Market strength indicators help investors to evaluate how HLS Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HLS Therapeutics shares will generate the highest return on investment. By undertsting and applying HLS Therapeutics pink sheet market strength indicators, traders can identify HLS Therapeutics entry and exit signals to maximize returns
HLS Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for HLS Therapeutics' price direction in advance. Along with the technical and fundamental analysis of HLS Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of HLS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0294 | |||
| Jensen Alpha | 0.0409 | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | 0.0014 | |||
| Treynor Ratio | 0.151 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for HLS Pink Sheet analysis
When running HLS Therapeutics' price analysis, check to measure HLS Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLS Therapeutics is operating at the current time. Most of HLS Therapeutics' value examination focuses on studying past and present price action to predict the probability of HLS Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLS Therapeutics' price. Additionally, you may evaluate how the addition of HLS Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |